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and §Department of Materials and Interfaces, Weizmann Institute of Science, Rehovat, IsraelABSTRACT Grazing incidence x-ray diffraction measurements were performed on single hydrated bilayers and monolayers
of Ceramide/Cholesterol/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocyholine at varying concentrations. There are substantial
differences in the phase and structure behavior of the crystalline domains formed within the bilayers relative to the corresponding
monolayers, due to interactions between the opposing lipid leaflets. Depending on the lipid composition, these interactions lead
to phase separation and formation of cholesterol crystals. The cholesterol and ceramide/cholesterol mixed phases were further
characterized at 37C by immunolabeling with specific antibodies recognizing ordered molecular arrays of cholesterol. Previous
studies have shown that cholesterol may nucleate in artificial membranes to form thick two-dimensional bilayer crystals. The
study herein demonstrates further growth of cholesterol into three-dimensional crystals. We believe that these results may
provide further insight into the formation of cholesterol crystals in early stages of atherosclerosis inflammation.INTRODUCTIONCell membranes are composed of lipid domains, which
differ one from the other in composition, location, size,
stability, and structure, and are believed to be essential to
cell functionality by acting as protein platforms (1–5). Satu-
rated lipids and sterols may spontaneously form in vitro
crystalline domains with typical sizes of a few nanometers
(6). Cholesterol, the most abundant sterol in mammalian
cell membranes, was shown to form in vitro bilayer thick
crystalline domains made of thousands of molecules (7).
Cholesterol crystals are involved in several pathologies,
including atherosclerosis, and were suggested to be an early
cause rather than a late consequence in the genesis of
atherosclerosis (8). Ong et al. (9) recently suggested, based
on studies in cell culture, a model for initiation of athero-
sclerosis from cholesterol crystal nuclei formed at the cell
membrane interface. We independently demonstrated the
conditions under which such nucleation processes may
occur in supported lipid bilayers (7,10–12).
Studies of the packing motifs and sizes of crystalline
domains in single hydrated lipid bilayers have recently
been made possible by the use of grazing incidence
x-ray diffraction (GIXD) under high humidity (11). These
measurements, performed on hydrated bilayers of choles-
terol/sphingomyelin or cholesterol/DPPC (di-palmitoyl-
phosphatidyl-choline), showed the formation of 35A˚ thick
cholesterol crystals, which are composed of two opposing
cholesterol leaflets, i.e., bilayer crystals. These crystals,
however, did not grow further into three-dimensional (3D)
crystals and did not undergo transformation from a 10 
7.5 A˚2 rectangular phase into the 12.4  12.4 A˚2 triclinicSubmitted February 17, 2012, and accepted for publication May 16, 2012.
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. Open access under CC BY-NC-ND license.phase found in atherosclerotic plaques (13,14). The choles-
terol levels required for cholesterol nucleation to occur were
shown to depend on the lipid composition of the bilayer
membrane.
The conditions required to foster the transition of choles-
terol crystals from the rectangular phase limited to two
dimensions to the triclinic phase found in 3-dimensional
(3D) crystals may be crucial for the understanding of
phenomena possibly occurring in pathological conditions.
Intrigued by this we chose to study cholesterol nucleation
when mixed with ceramide, the lipid that forms the back-
bone of all sphingolipids, but does not have the large phos-
phocholine headgroup of sphingomyelin or DPPC (See
Chart). Knowledge of the Ceramide/Cholesterol phase
behavior is available in monolayers (15,16) and vesicles
(17,18). Ceramide is a saturated sphingolipid, which in itself
participates in cell signaling, and also serves as a precursor
of more complex sphingolipids. At least six genes have been
identified, which produce enzymes synthesizing ceramides
with alkyl chains of different lengths (19,20).
We investigate the conditions of phase separation of
cholesterol from mixed phases with ceramide to the two-
dimensional (2D) or 3D crystalline phases, combining two
distinct approaches that we initiated in our laboratory:
GIXD under high humidity and structural antibodies. Using
GIXD at high humidity, we provide further insight into
the interactions between the opposing leaflets in the sup-
ported membrane, relative to monolayers with the same
composition.
Structural antibodies are selected to recognize specific
structural packing motifs in ordered arrays of molecules,
in the present case lipids: they do not bind to one lipid mole-
cule but to an array of lipid molecules in specific ordered
supramolecular organizations (21). We have isolateddoi: 10.1016/j.bpj.2012.05.025
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on the surface of cholesterol crystals and monolayers
(MAb58B1) (22) and of ceramide/cholesterol mixed phase
monolayers (MAb405F) (15). Both antibodies were previ-
ously used to recognize their specific antigen molecular
arrays in cells and tissues, and were thoroughly character-
ized both on lipid layers (15,23) and in cells (9,24–26).
Humidity GIXD studies could not be performed at phys-
iological temperatures. Therefore, to prove the existence
of cholesterol crystals in the supported bilayers at a physio-
logical temperature, we use MAb58B1 and MAb405F to
fluorescently label cholesterol crystals and Ceramide C16/
Cholesterol (hereafter Cer/Chol) domains, respectively, at
both 7 and 37C.
The results show that cholesterol crystals indeed nucleate
in hydrated bilayers of Cer/Chol at low temperature as well
as at physiological temperatures, and that the 2D cholesterol
crystals spontaneously transform into 3D crystals.MATERIALS AND METHODS
Samples preparation and experimental methods are summarized below. For
further details, including antibody purification, vesicle formation atomic
force microscopy (AFM), and microscope setup, we refer the reader to
the Supporting Material.Bilayer deposition by Langmuir trough
The desired proportion of lipids is dissolved in chloroform and spread onto
Langmuir trough preheated to 40–50C. Ten minutes later the lipid mono-
layer at the air-water interface is compressed to 30 mN/m. Bilayer deposi-
tion is made by the water drained Langmuir trough followed by Langmuir
Schafer (WDL-LS) techniques; the water is drained out of the trough,
lowering the lipid monolayer on top of a silicon/quartz wafer covered
with a polyethyleneimine (PEI) cushion, which lies at the bottom of the
trough. The wafer is lifted and placed upside down on top of a water-filled
Teflon plate, placed in advance at the bottom of the trough, and now coveredBiophysical Journal 103(2) 255–264with a lipid monolayer as well (12). Once placed onto the Teflon plate, the
wafer is gradually cooled down to 4C, and kept at this temperature until
AFM or GIXD experiments are performed.
Before the GIXD experiment, a second PEI cushion layer is deposited
on top of the bilayer by immersion in 1000 ppm PEI for 10 min and
then washed. Water comprises 85% of the PEI cushion volume (27). The
bilayer sample is constantly kept under either water or high humidity. After
deposition of the PEI layer, the contact angle of the bilayer is ¼ 0.
Samples that contain cholesterol molecules remain intact for long periods
when 10% palmitoyloleoyl phosphatidylcholine (POPC) is added to the
mixture.Bilayer deposition by vesicle fusion
To obtain supported bilayers, the vesicle suspensions are spread on hydro-
philic glasses (Thermo Scientific Menzel-Glaser 13 mm diameter and 1 mm
thick) or silicon wafers (SESO silicon wafers 32.5 mm diameter and
3.5 mm thick), such that the water suspension covers completely the surface
(0.5 ml for immunofluorescence or 1.5 ml for AFM). The sample is heated
above 92C for 15 min to induce vesicle adhesion, fusion, and rupture on
the surface. After the fusion, three washings are performed to remove the
excess vesicles in suspension.Immunofluorescence
Lipid bilayer mixtures supported on glass and covered by 2.5 ml of milli-Q
grade water are heated to 37C on a water thermostat or cooled to 7C in
a controlled refrigerator. The sample is incubated with monoclonal anti-
body 58 B1 or 405F (final concentration 1.5 mg/ml) for 20 min. After three
washings a labeled secondary antibody (Rhodamine (TRITC)-AffiniPure
Donkey Anti-Mouse IgM, m-Chain Specific, Jackson ImmunoResearch
Laboratories) is injected to reach a final concentration of 12 mg/ml. After
20 min the sample is washed three times and observed under epifluores-
cent light with a rhodamine filter (575 nm). All the experiments are per-
formed in parallel under the same conditions to avoid artifacts that
might result from antibody aggregation. For each experiment 5–7 images
are recorded in different areas of the glass. Exposure and signal gain are
kept constant for all experiments. Each set of experiments is repeated at
least three times.Humidity GIXD set-up
Experiments are performed at beamline BW1 at the DORIS III Synchrotron
DESY, (Hamburg, Germany). The methodology was previously introduced
and described (11). Briefly, the sample is completely wet when placed
inside the humidity chamber; a controlled evaporation process is then initi-
ated to enable GIXD measurements. The chamber is filled with humidified
Helium. Relative humidity, gas temperature, and sample temperature are
monitored and maintained by PID feedback loops. The measurements are
performed under continuous control of temperature and humidity. Control
studies on monolayers deposited at the air/water interface were performed
at the same beamline using a liquid surface diffractometer (28,29). All
GIXD measurements were performed at sample temperatures of ~6–7C.RESULTS
GIXD measurements
X-ray is strongly scattered by water, yet lipid bilayers
require wetting on both sides, to preserve their integrity.
Therefore, to obtain measurable and reliable x-ray diffrac-
tion signals, GIXD measurements are performed while
Formation of 3D Cholesterol Crystals in Lipid Bilayers 257preserving membrane integrity under high humidity condi-
tions under which a thin (<1 mm) water layer covers
the sample. The measurements of single hydrated bilayers
were performed using a homemade setup described
previously and summarized in the Experimental section
(6,11,12). For further reading on the different methodolo-
gies of x-ray diffraction on lipid membranes, we refer the
reader to a recent review (6).
Lipid bilayer mixtures composed of ceramide C16 and
cholesterol in different ratios, and a fixed ratio of 10%
POPC, was deposited by WDL-LS (see Materials and
Methods) and their x-ray diffraction was examined by
GIXD. POPC is an unsaturated glycerolipid with a kinked
aliphatic chain. For this reason POPC cannot pack in
ordered structures and does not mix with the ceramide/
cholesterol crystalline domains, because the kinked side
chain requires a much larger molecular cross section. It
may be present at the periphery of crystalline domains, as
was previously suggested (30–32), yet this is not expected
to affect the unit cell dimensions. The presence of the unsat-
urated lipid provides stability to the bilayers by enhancing
their mobility and elastic properties. In addition, domains
in biological membranes are immersed in a lipid medium
composed mostly of unsaturated lipids (33–35).
Fig. 1 shows Bragg peaks of Cer/Chol/POPC bilayers
at 100:0:0 mol%, 72:18:10 mol%, 54:36:10 mol%, and
36:54:10 mol%, corresponding to Cer/Chol ratios of 80:20,
40:60, and 60:40, respectively.
The Bragg peaks obtained from monolayers of similar
compositions are presented for comparison. The surface
pressure of deposited bilayers cannot be measured directly,
although deposited at 30 mN/m, bilayers may have relaxed
to a lower surface pressure after deposition. We therefore
present monolayer data both at surface pressure P ¼
30 mN/m and at negligible pressure P ¼ 1.5 mN/m. The
monolayers were scanned shortly after deposition, whereas
the bilayers were deposited 6–48 h before GIXD scans.
POPC does not contribute to the diffraction signals. Bragg
peaks were fitted using Voigt functions, and are presentedin deconvolution in Fig. 2. Each Bragg peak is colored
according to the corresponding phase.
The monolayers at P ¼ 1.5 mN/m and compositions
100:0:0 and 72:18:10 mol% Cer/Chol/POPC show two
peaks corresponding to one crystalline phase, which belongs
to pure ceramide, marked green in Fig. 2 A (15,36). When
compressed to P ¼ 30 mN/m the monolayers still show
one pure ceramide phase, characterized by one sharp peak
at qxy¼ 1.52 A˚1 (Fig. 1 B): compression of the monolayer
lowers the molecular tilt and leads to one peak composed of
{(1,1), (1,1), and (0,2)} reflections, instead of the two
peaks, which are seen in the uncompressed monolayer. At
a composition of 54:36:10 mol% Cer/Chol/POPC a broad
Bragg peak at qxy ¼ 1.29 A˚1, which belongs to a mixed
Cer/Chol phase (marked blue in Fig. 2 C), appears both at
P ¼ 1.5 and P ¼ 30 mN/m in addition to the pure ceramide
phase. The mixed phase is also observed at composition
36:54:10 mol % Cer/Chol/POPC at both pressures, whereas
the ceramide phase exists only in the compressed monolayer
and not at P ¼ 1.5 mN/m (Fig. 2 D). The latter result indi-
cates that the crystalline ceramide phase separated upon
compression of the monolayer. Previous studies performed
on uncompressed ceramide monolayers showed sponta-
neous transformation of the crystalline ceramide phase after
a few hours from deposition (15). The measurements pre-
sented in Fig. 1 were performed before this transition.
The Bragg peak of the pure ceramide bilayer (Fig. 2 A) is
located at qxy ¼ 1.517A˚1, corresponding to a d-spacing of
4.142 A˚, and the Bragg rod is located at qz~0 A˚
1, indicating
that the alkyl chains are perpendicular to the bilayer plane.
Describing the compressed monolayer and bilayer by rect-
angular unit cells yields dimensions a ¼ 4.77 A˚ b ¼
8.25 A˚ and a ¼ 4.78 A˚ b ¼ 8.29 A˚, respectively. These
cell dimensions are fingerprint evidence in favor of pseudo
shallow glide symmetry. In both systems the chain tilt angle
is close to 0 and the lateral coherence lengths are 145 5
10 A˚, and 115 5 10 A˚, for the monolayer and bilayer
systems, respectively. The full width at half-maximum
(FWHM) of the Bragg rod of the bilayer (Fig. S1 in theFIGURE 1 Bragg peaks of ceramide/choles-
terol/POPC mixtures at varying ratios, from mono-
layers with surface pressure of 1.5 and 30 mN/m,
and from bilayers deposited at 30 mN/m. The
intensity of each plot was factorized for conve-
nience of presentation.
Biophysical Journal 103(2) 255–264
FIGURE 3 Diffraction data from a 36:54:10 Cer/Chol/POPC bilayer. Top
plot presents the peaks after deconvolution, colored according to phases:
ceramide phase – green, mixed Cer/Chol phase – blue, cholesterol rectan-
gular phase – red and cholesterol triclinic phase black. Each Bragg peak is
labeled with Miller indices. The Bragg rods corresponding to each peak are
given below, labeled and colored accordingly.
FIGURE 2 Deconvolution of Bragg peak components fitted by Voigt
functions. Each peak is colored according to the phase it represents; ceram-
ide – green, mixed Cer/Chol – blue, cholesterol rectangular phase – red, and
cholesterol triclinic phase – black.
258 Ziblat et al.Supporting Material) is similar to that of the monolayer,
indicating that the two leaflets scatter independently.
The Bragg peaks of the Cer/Chol/POPC bilayer are
different from those of the monolayers at compositions
with higher Chol levels. The Bragg peak of the 72:18:10
mol% Cer/Chol/POPC bilayer is composed of five discern-
ible peaks (Fig. 2 B), suggesting the existence of two
crystalline phases, similar to those observed for the ceram-
ide monolayer before and after transformation. Part of these
peaks is also visible at the 54:36:10 mol% Cer/Chol/POPC
ratio (Fig. 2 C), but the most dominant peak at qxy ¼
1.51 A˚1 has decreased. A broad peak at qxy ~1.35 A˚
1
appears, which belongs to a mixed Cer/Chol phase.
The Bragg peaks of the 36:54:10 mol% Cer/Chol/POPC
bilayer along with their Bragg rods are shown in Fig. 3:
each phase is colored accordingly as in Fig. 2. The bilayer
shows four crystalline phases: a ceramide phase (marked
green) characterized by the wide weak peak at qxy ¼
1.52 A˚1, a mixed Cer/Chol phase (marked blue) repre-
sented by the wide peak at qxy ¼ 1.25 A˚1, a crystalline
Chol phase with rectangular cell (marked red), and a second
Chol phase (marked black), which may belong to a distorted
triclinic cell (Fig. 2 D). The Bragg rods of the rectangular
phase show a striking similarity to the Bragg rods of the
rectangular phase previously reported by Rapaport et al.
and Solomonov et al. (7,10) Their positions at qxy ¼ 0.83,
1.03, 1.23, 1.51 A˚1 are similar as well. The FWHM ofBiophysical Journal 103(2) 255–264the Bragg rods suggests that the sample is composed of
single bilayers and of tetralayers composed of two bilayers
of cholesterol. Optimal fit is achieved for a mixture consist-
ing of 40% bilayers and 60% tetralayers. (Fig. 3) The rect-
angular phase is of monoclinic lattice symmetry and is
a monohydrate phase.
In previous studies thick cholesterol monohydrate crys-
tals were shown to have a triclinic cell phase with a ¼
b¼ 12.4 A˚ (7,10,37,38). This corresponds to the cholesterol
monohydrate phase, which is found in atherosclerotic pla-
ques in the form of 3D crystals (39). The Bragg peaks,
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to the cholesterol triclinic phase, however attempts to fit
the data with an a ¼ b triclinic cell were unsuccessful.
Therefore, we conclude that these peaks may belong to a
distorted triclinic (t) cell with a ¼ 12.5, b ¼ 12.1 A˚, and
g ¼ 101.3, which explains the split of the {(2,0)t, (0,2)t},
{(2,1)t,(1,2)t}, and { (2,1)t (1,2), t} Bragg peaks. The
Bragg rod of the (2,1)t seems to have about half the
FWHM of the other triclinic Bragg rods. This could suggest
that the cholesterol molecules in the (2,1)t plane are in
registry along the z axis, whereas in other planes they are
not. Nevertheless, the positions of the (2,1)t and (2,2)t
Bragg peaks fall on the wide and intense Bragg peak of
the mixed Cer/Chol phase. The Bragg rod of the mixed
phase was therefore subtracted from the (2,1)t and (2,2)t
rods. However, because the intensity of the mixed Cer/
Chol is substantially stronger than that of the triclinic phase,
the resulting Bragg rods are likely to have a large error and
should be considered with caution. No fit data of these
Bragg rods are presented. A summary of all unit cells and
phases is given in Table S1.
Fig. 4 shows GIXD data, comparing bilayers with
high cholesterol levels; 36:54:10 mol% Cer/Chol/POPC
measured a few hours after deposition, and both 36:54:10
mol% Cer/Chol/POPC and 18:72:10 mol% Cer/Chol/
POPC measured 1 day after deposition. Comparison of theFIGURE 4 2D to 3D nucleation by Bragg peaks obtained from bilayers
of (A) 36:54:10 mol% Cer/:Chol/POPC 6 h after deposition, (B) 36:54:10
mol% Cer/Chol/POPC 1 day after deposition, and (C) 18:72:10 mol%
Cer/Chol/POPC more than 1 day after deposition. Bragg peaks of the 2D
rectangular phase decrease, whereas Bragg peaks of the 3D triclinic phase
increase from A through B to C.fresh and older 36:54:10 mol% Cer/Chol/POPC sample
shows an increase of the Bragg peaks of the triclinic
phase (marked by gray lines), whereas the relative inten-
sity of the peaks pertaining to the rectangular phase
decreases, indicating the formation of increasing amounts
of cholesterol monohydrate crystals at the expense of the
rectangular phase. Comparison with the 18:72:10 mol%
Cer/Chol/POPC bilayer sample shows an even further
increase of the triclinic phase. Note that in the latter two
samples 1% and 1.4% cholesteryl acetate were added,
respectively.AFM measurements of mixed phases
Measurements of domain height were derived from AFM to
compare samples prepared with two different sample prep-
aration techniques: from WDL-LS and from vesicle fusion
(see Materials and Methods). The latter was adopted to
allow contemporaneous preparation and examination of
several samples for immunofluorescence experiments (see
below), which cannot be achieved when using the former
technique. Sample preparation and observation was done
in the same day to avoid sample transformations. In the
vesicle fusion, 40 mol% POPC is added to the choles-
terol/ceramide mixture, rather than 10% as in the WDL-
LS technique. This is aimed at inducing liposome
formation, under conditions in which only multilamellar
deposits would be formed in the absence of the unsaturated
lipid. Because POPC is unsaturated, it cannot be incorpo-
rated into the crystalline unit cell of the mixture. Therefore,
it is unlikely that the higher percentage of POPC used to
form vesicles will influence the ceramide/cholesterol
domain structure. At least three independently prepared
specimens were analyzed for each experimental condition
examined, and each sample was observed in several
different locations for consistency.
AFM scans of the 36:54:10 mol% Cer/Chol/POPC
bilayer (Cer/Chol ¼ 40:60), prepared by the WDL-LS
technique, and performed a few hours after deposition, re-
vealed bilayer thick samples without any thicker domains
(Fig. 5 A). AFM studies of the 18:72:10 mol% Cer/Chol/
POPC sample showed on part of the scanning locations
a tetralayer stack lying on top of the bilayer sample
(Fig. 5 B). This stack has straight and sharp edges indica-
tive of a highly crystalline domain. The size of the crystal
observed by AFM is in the microscale, whereas the FWHM
of the triclinic Bragg peaks show a coherence length of
35 nm, suggesting that the micron-sized crystals are not
single domains. Samples composed of 100:0:0, 72:18:10
(Cer/Chol ¼ 80:20) and 54:36:10 (Cer/Chol ¼ 60:40)
mol% Cer/Chol/POPC show bilayer thick samples (see
Table S1). Samples of composition 24:36:40 mol% Cer/
Chol/POPC (Cer/Chol ¼ 40:60) prepared with the vesicle
fusion technique showed both bilayer thick and tetralayer
thick (Fig. 5 C) regions, with prevalence of the former.Biophysical Journal 103(2) 255–264
FIGURE 6 Epifluorescence micrographs of antibody-bound bilayer.
24:36:40 mol% Cer/Chol/POPC labeled with MAb 58B1 at 7C (A) and
at 37C (B); (C and D) 24:36:40 mol% Cer/Chol/POPC bilayers labeled
with MAb 405F at the same temperatures. The sample at 7C is inhomoge-
neous and displays two distinct phases, different in their fluorescence inten-
sities. (C) Shows both types of regions. (E) 25:75 mol% Chol/POPC bilayer
labeled with MAb 58B1 (positive control) and (F) with MAb 405F as
a negative control, at 37C. Antibody concentration is 1.5 mg/ml; exposure
time for all micrographs is 9 s.
FIGURE 5 AFM bioscope height images, measured in wet tapping
mode. The compositions of the samples are specified in the figure as ratios
of Cer/Chol/POPC. Each scan is 5 mm  5 mm, and the z color range is
between 0 and 25 nm. Images were linearly flattened. (A and B) Deposited
using the WDL-LS technique. (C) Bilayers and tetralayers deposited by
vesicle fusion. Lines on the AFM images represent the locations of height
profile cuts that are given on the right side. In these profiles, 5 and 10 nm
thick correspond to a bi- and tetralayer, respectively.
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The GIXD experiments were performed at 7C for improve-
ment of signal/noise ratio. To establish whether cholesterol
phase separation occurs also at body temperature, which
may be relevant for the genesis of cholesterol crystals in
atherosclerosis, we embarked on a series of comparative
experiments at 7 and 37C, where the phase separation of
cholesterol is followed by antibody labeling.
Bilayers were prepared from fusion of vesicles, as
described previously for the AFM samples. As the antibody
labels only domains exposed at the interface with water, the
presence of tetralayers identified in these samples by AFM
should not cause any major change in the results. To avoid
missing major artifacts, however, samples prepared in the
same manner were examined in parallel at the two temper-
atures. Positive and negative controls were run also in
parallel at the two temperatures to verify that the differences
in temperature do not cause intrinsic labeling artifacts. All
micrographs were recorded under exactly the same condi-
tions. Whole sets of samples to be compared were prepared,
incubated, and observed on the same day. For each sample atBiophysical Journal 103(2) 255–264least five different areas were recorded of which the micro-
graphs reported are representative.
Cholesterol domain formation was studied in mixtures at
compositions 24:36:40 mol% Cer/Chol/POPC, correspond-
ing to a ratio of Cer/Chol ¼ 40:60, as used in the GIXD
and AFM experiments. MAb 58B1 (recognizing cholesterol
crystals) (22) and MAb 405F (recognizing cholesterol/
ceramide C16 mixed domains) (23,25) were used. Mixed
lipid bilayers are visualized by epifluorescence microscopy
after incubation with a secondary fluorescently labeled
antibody.
MAb 58B1 labeling (white areas) is more intense at lower
temperatures, but has the same order of magnitude at the
two temperatures, indicating that substantial phase separa-
tion of cholesterol occurs also at 37C (Fig. 6, A and B).
Interestingly, the image is clearly composed of closely
packed light and dark micrometer-wide regions, at the limit
of the resolution of the light microscopy method used here.
These cannot correspond to the domains observed by GIXD,
because the latter are much smaller. Their larger size may
indicate aggregation of smaller crystalline domains. Alter-
natively, each smaller crystalline domain may be associated
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Significant labeling was observed at composition 25:75
mol% Chol/POPC at 37C, even though the cholesterol
level is lower than in the 24:36:40 mol% Cer/Chol/POPC
(see Fig. 6 E). This is due to cholesterol’s tendency to phase
separate from the unsaturated POPC, and to the lack of
a saturated lipid such as Cer.
The same micrometer domain structure is observed also
when the samples are labeled with MAb 405F, specifically
binding the ceramide/cholesterol mixed phase. MAb 405F
labeling at 37C is homogeneous and relatively strong,
indicating the presence of the mixed phase in substantial
amounts. In contrast, MAb 405F at 7C labels more in-
tensely some areas of the sample relative to others
(Fig. 6 C). This may be due to an additional phase separation
that is not complete in all regions, such as the formation of
ceramide domains observed by GIXD, or possibly to segre-
gation of POPC. No labeling of MAb 405F was seen on
25:75 mol% Chol/POPC bilayer at 37C, as should be ex-
pected (Fig. 6 F). In conclusion, at both temperatures the
coexistence of segregated cholesterol and mixed phase
was observed, although there are differences in their relative
proportions.DISCUSSION
Ceramide C16
The C16-ceramide crystalline domains in the bilayer
are monolayer thick and have similar thickness and almost
identical unit cell dimensions as the ceramide crystalline
domains in the monolayer (Fig. S1, Table S1). This suggests
that the interactions between opposing leaflets in the bilayer
are minimal, and because each leaflet scatters indepen-
dently, we conclude that no bilayer-thick crystals are formed
in the 100:0:0 Cer/Chol/POPC samples. Both compressed
monolayers and bilayers of the pure ceramide samples
show one x-ray diffraction peak indicative of a pseudohexag-
onal unit cell, which can be described more appropriately as
a rectangular unit cell with a g angle of 90 (41).
The bilayers with compositions 72:18:10 mol% and
54:36:10mol%Cer/Chol/POPC show two crystalline phases
of ceramide, both of which have a near-rectangular unit cell
(Table S1) and were reported previously in pure ceramide
monolayers (15). Cholesterol does not incorporate into
the crystalline domains of ceramide, and is thus probably
located in an amorphous phase. The crystalline domains
in an uncompressed ceramide monolayer are initially in
a metastable state and within hours of deposition undergo
a complete phase transition (15). Interestingly, in contrast
to the monolayer, bilayers do not show a complete phase
transition even when measured >24 h after deposition. It is
conceivable that the molecule exposure to the opposing lipid
leaflet has an effect on the transition process. The lifetime
of lipid domains in cell membranes is currently unknown,however all reports of domain lifetime are substantially
shorter than hours (42). Hence, the first phase, i.e., the phase
obtained upon deposition, is probably the most significant.
The mixed Cer/Chol phase is formed immediately upon
deposition and is not followed by spontaneous phase transi-
tions. Therefore, the results obtained here on the mixed
phase and the subsequent segregation of cholesterol crystals
are likely to be unaffected by the ceramide phase transition,
whatever the lifetime of the domains.Mixed ceramide cholesterol phases
Monolayers containing saturated lipids, unsaturated lipids,
and cholesterol generally undergo phase separations where
most of the unsaturated lipids are in liquid-disordered
domains and most of the saturated lipids and cholesterol
are in liquid-ordered domains. Raising either the tempera-
ture or the pressure above a critical value leads to one
uniform liquid phase (43). In this study we witness an oppo-
site effect: Once compressed, the ceramide phase separates
from the Cer/Chol mixed phase in the samples of 40:60 and
60:40 mol % ratios. A similar transition from a uniform
phase to a coexisting liquid phase was reported to occur in
cholesterol upon increasing the surface pressure (44). This
phenomenon raises an important question, which to date
has received little attention, i.e., what is the surface pressure
in a cell membrane? Comparison of the activity of phospho-
lipase in erythrocytes relative to monolayers led to a general
belief that the surface pressure in cells is 30–35 mN/m (45).
However, it is likely that the activity of phospholipase in
cells is affected by other parameters in addition to surface
pressure. We should be aware there is no definite measure-
ment of surface pressure in cell membranes, or that the
pressure remains constant in time.
Physical studies of lipid domains performed by fluores-
cence on supported bilayers (46,47) and using unilamellar
vesicles (48–51) have shown micrometer-sized phase
domains to exist. X-ray diffraction studies have shown that
what is defined as ordered domains detected by optical
microscopy,may contain crystalline domains. The coherence
lengths of the crystalline domains were found to be nano-
meter scale. Langmuir deposited monolayers that contain
such crystalline domains have also been shown to maintain
fluidity properties, even when compressed (52). It was
subsequently suggested that the micrometer-size phase
domains contain nanometer-sized crystalline domains with
an amorphous phase interleaved with the crystalline domains
(6). The images obtained by immunolabeling, show the pres-
ence of relatively large domains, also indicating that the
ordered phase domain may contain an inhomogeneous
distribution of crystalline domains, and possibly amorphous
phases.
Cholesterol nucleation studies performed on Chol
mixtures with either sphingomyelin (SM) or DPPC in single
hydrated bilayers proved that phases of pure Chol nucleateBiophysical Journal 103(2) 255–264
262 Ziblat et al.beyond certain threshold values of composition to form
crystalline bilayers in the rectangular phase (11,12).
The triclinic phase of cholesterol, to date, was never
observed to exist as a bilayer thick crystal. It seems that
its formation requires a higher number of layers to nucleate.
The rectangular phase, in contrast, exists both as a bilayer
thick crystal and as a multilayer. The appearance of the
triclinic phase at a composition of 36:54:10 mol% Cer/
Chol/POPC indicates that Chol bilayer crystals can sponta-
neously transform into 3D crystals (Fig. 7). As the Bragg
rods of the rectangular phase (Fig. 3 in red) belong to
both bi- and tetralayer thick crystals, it is reasonable that
the triclinic phase results from transformation of the tetra-
layer thick rectangular crystals, although it might also
have nucleated spontaneously. Tetralayer thick crystals of
the rectangular phase were not seen in cholesterol mixtures
with SM or DPPC, nor were the triclinic phase ever
observed. A likely explanation is that the bulky headgroup
of the phosphocholine lipids prevents folding of the bilayer
on itself, whereas the small hydroxyl headgroup of the
ceramide cannot inhibit such a folding. We note that the
inhibition can be kinetic, rather than thermodynamic. In
addition, the nucleation of the triclinic phase may be facil-
itated, under pathological conditions, by the addition of
cholesterol from a source external to the cell membrane,
such as a second bilayer from a vesicle or an extracellular
particle (9). Estimation of the threshold for Chol crystalliza-
tion from the ceramide/cholesterol mixed phase is more
complicated relative to previous SM/Chol and DPPC/Chol
studies (11,12). There are two Chol crystalline phasesFIGURE 7 Schematic representation of 40:60 Cer/Chol samples of
monolayer at P ¼ 1.5 and 30 mN/m, and a bilayer deposited at P ¼
30 mN/m. Crystalline domains are schematically illustrated colored accord-
ing to phases: Ceramide phase, green; mixed ceramide/cholesterol phase,
blue; cholesterol rectangular phase, red; and cholesterol triclinic phase, gray.
Biophysical Journal 103(2) 255–264(i.e., the rectangular and triclinic phases), instead of one.
Therefore, intensity ratios between the mixed phase and
the Chol rectangular phase cannot be performed as they
were performed in previous studies. In addition, as the
ceramide molecules participate in both ceramide and Cer/
Chol phases, knowledge of the amount of cholesterol mole-
cules in the mixed phase cannot be extrapolated from the
position of the mixed phase peak. The SM/Chol and the
DPPC/Chol system showed crystalline thresholds of 38
mol% cholesterol, and 54 mol% cholesterol, respectively.
The Chol crystal Bragg peaks of DPPC/Chol mixtures
at a composition of 40:60 mol% has a very low intensity
relative to the mixed phase. The Cer/Chol mixtures have
Chol crystal peaks with considerably higher intensity,
even though part of the Chol appears in the triclinic phase.
Judging from the above, we can evaluate that the threshold
for crystallization of Chol from the Cer/Chol mixtures is
substantially lower than 54 mol%. On the other hand, no
cholesterol crystals were observed at 60:40 mol% Cer/
Chol composition, whereas in the SM/Chol mixture, choles-
terol crystal diffraction is observed at this composition. We
therefore estimate that the threshold for cholesterol nucle-
ation in the Cer/Chol bilayer has an intermediate value of
455 5% cholesterol (6). At body temperature, as the immu-
nolabeling results suggest, the threshold for nucleation is
also well under 60% cholesterol. Studies on cholesterol
miscibility and crystallization in Cer/Chol vesicles were
previously reported (17,53), however these were not per-
formed on a single hydrated bilayer, i.e., in unilamellar
vesicles. Therefore, the phase behavior may be affected by
temporary contact with adjacent membranes, and choles-
terol crystallization events through the intermediate rectan-
gular phase may be impossible to observe.
We finally note that the conclusions drawn on cholesterol
nucleation in this study apply to symmetrical bilayers,
whereas in cells the membrane composition is asymmetric.
The cholesterol distribution between the opposing leaflets
in cell membranes is still a debated issue. Cholesterol
nucleation occurs by a partial interdigitation of opposing
cholesterol molecules. Therefore, the nucleation threshold
depends on the local amount of cholesterol molecules in
each of the opposing leaflets and not on the total amount of
cholesterol. It was however shown that domains with corre-
sponding phase order in opposing leaflets have a tendency
to juxtapose (54,55); Considering this tendency, and the
evidence indicating that cholesterol preferentially resides
in ordered domains, the probability of cholesterol locally
aggregating in juxtaposed opposing leaflets may be higher
than what would be expected from a random statistical count.CONCLUSIONS
Similar to studies performed on sphingomyelin/cholesterol
and DPPC/cholesterol mixtures, ceramide/cholesterol
mixtures behave differently in single hydrated bilayers
Formation of 3D Cholesterol Crystals in Lipid Bilayers 263than they do in monolayers. As in sphingomyelin/choles-
terol and DPPC/cholesterol mixtures, distinct cholesterol
phases separate out of the bilayer above a certain threshold
level, estimated to be 45 5 5% for ceramide/cholesterol
mixtures.
The ceramide/cholesterol bilayers differ, however, from
the others by the appearance of a 3D triclinic cholesterol
phase. It seems that the rectangular phase can spontaneously
transform into the triclinic phase, forming 3D crystals.
Immunofluorescence experiments, performed at body
temperature, show that the cholesterol crystals separate
from the lipid mixture with ceramide at 37C above the
same threshold level as they do at the lower temperature
used for x-ray diffraction experiments. This evidence
strengthens the possible relevance of the experiments to
the pathological conditions of atherosclerosis.SUPPORTING MATERIAL
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